Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
57.30
-1.70 (-2.88%)
Apr 17, 2026, 2:32 PM HKT

HKG:2315 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
45,42823,5853,3954,78510,245-
Market Cap Growth
573.02%594.71%-29.05%-53.29%--
Enterprise Value
44,31923,8593,5624,68210,003-
Last Close Price
59.0035.308.5011.9825.65-
PE Ratio
123.30122.3795.11---
PS Ratio
29.6115.373.256.0616.97-
PB Ratio
18.739.723.805.507.87-
P/TBV Ratio
19.249.994.135.738.12-
P/FCF Ratio
144.5475.0418.32---
P/OCF Ratio
110.2657.2415.10---
EV/Sales Ratio
28.8815.553.415.9316.57-
EV/EBITDA Ratio
115.8267.8813.92---
EV/EBIT Ratio
188.55101.5125.51---
EV/FCF Ratio
141.0175.9119.23---
Debt / Equity Ratio
0.270.270.680.690.360.07
Debt / EBITDA Ratio
1.701.702.14---
Debt / FCF Ratio
2.072.073.28---
Net Debt / Equity Ratio
-0.46-0.460.200.14-0.20-0.39
Net Debt / EBITDA Ratio
-3.17-3.170.69-0.710.491.16
Net Debt / FCF Ratio
-3.54-3.540.96-0.540.420.86
Asset Turnover
0.450.450.400.270.210.15
Inventory Turnover
2.492.493.7412.256.096.11
Quick Ratio
2.052.051.201.011.251.55
Current Ratio
2.312.311.531.251.521.96
Return on Equity (ROE)
11.48%11.48%4.12%-39.45%-50.12%-40.27%
Return on Assets (ROA)
4.30%4.30%3.37%-6.94%-14.81%-14.02%
Return on Invested Capital (ROIC)
16.18%17.82%10.76%-31.99%-71.53%-76.89%
Return on Capital Employed (ROCE)
7.60%7.60%7.00%-15.60%-27.60%-28.00%
Earnings Yield
0.42%0.82%1.05%-8.82%-6.64%-
FCF Yield
0.69%1.33%5.46%-4.68%-6.00%-
Payout Ratio
-8.69%45.29%---
Buyback Yield / Dilution
3.93%3.93%-5.26%-4.54%-5.13%-180.82%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.